PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Postgraduate Medical School, University of Chieti, Chieti, Italy.\', \'Istituto Ortopedico Galeazzi, Milano, Italy.\', \'Department of Orthopaedics, School of Medicine, University of L’Aquila, L’Aquila, Italy\', \'School of Pharmacy, University of Camerino, Camerino, Italy.\', \'Molecular Medicine, Department of Morphology, Surgery, Experimental Medicine, University of Ferrara, Ferrara, Italy.\', \'Department of Microbiology, University of Thessaloniki, Thessaloniki, Greece.\', \'Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.23812/Conti_Edit_35_2_1
?:doi
?:hasPublicationType
?:journal
  • Journal of biological regulators and homeostatic agents
is ?:pmid of
?:pmid
?:pmid
  • 33904269
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.407
?:rankingScore_hIndex
  • 37
is ?:relation_isRelatedTo_publication of
?:title
  • Monoclonal antibody therapy in COVID-19.
?:type

Metadata

Anon_0  
expand all